Cardlytics Inc (CDLX) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is currently in a bearish trend with weak financial performance, negative analyst sentiment, and no strong positive catalysts to support a long-term investment decision.
The stock is in a bearish trend with MACD below 0 and negatively expanding, RSI at 45.719 in the neutral zone, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support is at 0.903, and resistance is at 1.032. The stock closed at 0.9698, slightly above the pivot of 0.967.

Hedge funds are increasing their positions, with a 361.26% increase in buying over the last quarter.
Insiders are selling, with a 171.74% increase in selling activity over the last month. Analysts have lowered price targets, citing the impact of the BofA exit and Bridg divestiture. Financial performance is weak, with significant YoY declines in revenue, net income, EPS, and gross margin.
In Q4 2025, revenue dropped by -24.19% YoY to $56.1M, net income dropped by -47.08% YoY to -$8.25M, EPS dropped by -51.61% YoY to -0.15, and gross margin dropped by -3.28% YoY to 45.45.
Analysts have a neutral to bearish outlook on CDLX. Evercore ISI lowered the price target to $1 and maintained an In Line rating. Lake Street reduced the price target to $1.25 and maintained a Hold rating, citing near-term challenges and a 'show me' sentiment.